Companyon Ventures

Companyon Ventures is a Boston-based early-stage venture firm with a sharp thesis: they invest in B2B software companies at Series A and back founders with hands-on operating support during the post-Series-A growth-and-scale phase. The firm has built a reputation as a thesis-driven, capital-efficient investor that takes meaningful board roles and provides deep go-to-market and operating engagement. Healthcare exposure is selective but credible, with the fund’s pattern matching toward enterprise health-tech, vertical SaaS for healthcare providers and payers, and AI-augmented workflow tools where the buyer is rational and the sales motion is enterprise-software-shaped. Stage focus is Series A primarily, with check sizes plausibly $3M to $8M and a willingness to lead. For healthcare AI founders, Companyon is the right partner if you are a Series A B2B health-tech company — RCM, prior auth, ambient documentation, payer ops, clinical workflow, life-sciences software — with proven traction, strong unit economics, and a credible path to scaling beyond initial customer concentration. Founders who should approach: Series A enterprise health-tech founders with a clear ICP, repeatable sales motion, and ARR trajectory that meets Series A benchmarks; teams that value an active, operator-engaged board partner. Founders who should not approach: pre-seed and seed teams, consumer health, biotech, regulated medical devices, and any team whose business model does not fit the B2B software pattern. Companyon’s value-add is operating engagement at the board level, particularly in go-to-market, hiring, and pricing. Entry path is warm introduction through Boston-area operators, portfolio CEOs, or co-investors active in B2B health-tech Series A rounds.